Literature DB >> 12598423

Spinal amino acid release and repeated withdrawal in spinal morphine tolerant rats.

Takae Ibuki1, Martin Marsala, Takashi Masuyama, Tony L Yaksh.   

Abstract

1. We used spinal microdialysis in awake rats to investigate whether the repeated withdrawal with naloxone during continuous spinal infusion of morphine would lead to a progressively greater spinal glutamate release and a more pronounced intrathecal tolerance. 2. Rats received lumbar intrathecal (IT) infusion of morphine (IT-M: 20 nmol microl(-1) h(-1)) or saline (IT-S: 1 microl h(-1)) continuously for 3 days. Both groups were further subdivided to receive intraperitoneal (i.p.) injection of naloxone (IP-N: 0.6 mg kg(-1)) or saline (IP-S: 3 ml kg(-1)) every 24 h after the beginning of IT infusion. Daily thermal escape latencies, withdrawal signs, the resting basal release of spinal amino acids before IP injection and the release immediately after the injection (evoked) were measured. 3. Rats receiving IT morphine showed a maximum increase in thermal escape latency on day 1, after which this value declined, with the fastest decline observed in IT morphine + IP naloxone group. On day 1, no significant difference was observed among groups in the resting basal release of amino acids. Rats in IT morphine + i.p. naloxone group displayed a progressive increase in this value. The release was not significantly altered in other groups. 4. For the IT-M + IP-N group, basal resting dialysate concentrations of Glu, Asp and Tau rose steadily over the 3-day infusion interval. No change in basal resting release was noted for any other treatment. 5. Evoked release (after i.p. naloxone) in IT-M animals displayed a progressive increase over the three repeated exposures. Evoked release did not change significantly in other treatment groups. 6. The degree of precipitated withdrawal significantly correlated with the increase in glutamate acutely evoked by i.p. injection. 7. The present results show that periodic transient withdrawal of spinal opiate agonist activity leads to a progressive increase in glutamate outflow and withdrawal signs, in a manner consistent with an enhanced development of spinal tolerance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598423      PMCID: PMC1573708          DOI: 10.1038/sj.bjp.0705102

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  Inhibition by naloxone of tolerance and dependence in mice treated acutely and chronically with morphine.

Authors:  I Yano; A E Takemori
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1977-04

2.  The offset of morphine tolerance in rats and mice.

Authors:  B M Cox; M Ginsburg; J Willis
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

3.  Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion.

Authors:  C W Stevens; T L Yaksh
Journal:  J Pharmacol Exp Ther       Date:  1989-07       Impact factor: 4.030

4.  Quantitation of morphine tolerance induced by pellet implantation in the rat.

Authors:  H N Bhargava
Journal:  J Pharm Pharmacol       Date:  1978-02       Impact factor: 3.765

5.  Extracellular taurine increase in rat hippocampus evoked by specific glutamate receptor activation is related to the excitatory potency of glutamate agonists.

Authors:  N Menéndez; O Herreras; J M Solis; A S Herranz; R Martín del Río
Journal:  Neurosci Lett       Date:  1989-07-17       Impact factor: 3.046

Review 6.  The spinal biology in humans and animals of pain states generated by persistent small afferent input.

Authors:  T L Yaksh; X Y Hua; I Kalcheva; N Nozaki-Taguchi; M Marsala
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

Review 7.  The physiology of excitatory amino acids in the vertebrate central nervous system.

Authors:  M L Mayer; G L Westbrook
Journal:  Prog Neurobiol       Date:  1987       Impact factor: 11.685

8.  In vivo release from cerebral cortex of [14C]glutamate synthesized from [U-14C]glutamine.

Authors:  C M Thanki; D Sugden; A J Thomas; H F Bradford
Journal:  J Neurochem       Date:  1983-09       Impact factor: 5.372

9.  Intrathecal clonidine: analgesia and effect on opiate withdrawal in the rat.

Authors:  B Milne; F W Cervenko; K Jhamandas; M Sutak
Journal:  Anesthesiology       Date:  1985-01       Impact factor: 7.892

10.  A role for taurine in the maintenance of homeostasis in the central nervous system during hyperexcitation?

Authors:  A Lehmann; H Hagberg; A Hamberger
Journal:  Neurosci Lett       Date:  1984-12-21       Impact factor: 3.046

View more
  4 in total

1.  CXCR4 signaling mediates morphine-induced tactile hyperalgesia.

Authors:  Natalie M Wilson; Hosung Jung; Matthew S Ripsch; Richard J Miller; Fletcher A White
Journal:  Brain Behav Immun       Date:  2010-12-28       Impact factor: 7.217

Review 2.  Methadone: a new old drug with promises and pitfalls.

Authors:  Jodie A Trafton; Abhinav Ramani
Journal:  Curr Pain Headache Rep       Date:  2009-02

3.  Determining effective methadone doses for individual opioid-dependent patients.

Authors:  Jodie A Trafton; Jared Minkel; Keith Humphreys
Journal:  PLoS Med       Date:  2006-03       Impact factor: 11.069

4.  Chronic morphine administration enhances nociceptive sensitivity and local cytokine production after incision.

Authors:  DeYong Liang; Xiaoyou Shi; Yanli Qiao; Martin S Angst; David C Yeomans; J David Clark
Journal:  Mol Pain       Date:  2008-02-22       Impact factor: 3.395

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.